Background Over the course of 1 year, four patients in a single institution developed acute kidney injury most likely secondary to nafcillin-associated acute interstitial nephritis, indicating ...
March is Kidney Month! In November 2024, the American College of Rheumatology (ACR) released a summary of their new guidelines for the screening, treatment, and management of lupus nephritis. What is ...
Lupus nephritis is a serious complication of lupus — and because it doesn’t always cause symptoms right away, it’s important to find it early. Talk to your lupus doctor about getting screened (tested) ...
From the Medical Service, Mt. Sinai Hospital, New York City. Read before the Section on Internal Medicine, New York Academy of Medicine, April 16, 1929. Moschcowitz — Associate Physician, Mt ...
Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...
several case reports and a case series have indicated that PPIs have a causal role in the development of acute interstitial nephritis (AIN), which can progress to acute renal failure. Geevasinga ...
Hosted on MSN3mon
Researchers use electronic diagnostic model to predict acute interstitial nephritis in patientsMore information: Dennis G. Moledina et al, External Validation of an Electronic Health Record–Based Diagnostic Model for Histological Acute Tubulointerstitial Nephritis, Journal of the American ...
The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of lupus nephritis.
From the Medical Service, Mt. Sinai Hospital, New York City. Read before the Section on Internal Medicine, New York Academy of Medicine, April 16, 1929. Moschcowitz — Associate Physician, Mt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback